Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Sickle Cell Disease Clinical Trials

103 recruiting trials for Sickle Cell Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
103
Total Trials
103
Recruiting Now
5
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGNCT06147414

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Cell-free fetal DNA (cffDNA) is present in the maternal blood from the early first trimester of gestation and makes up 5%-20% of the total circulating cell-free DNA (cfDNA) in...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 5501 location
RECRUITINGNCT06539169

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

FLOWER is a completely virtual, nationwide, real-world observational study to collect, annotate, standardize, and report clinical data for rare diseases. Patients participate in...

Sponsor: xCuresEnrolling: 10001 location
RECRUITINGNCT06477289

Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease

This study will examine sleep disordered breathing and sleep quality in participants (ages 12-18) diagnosed with sickle cell disease of any genotype. We will utilize remote...

Sponsor: St. Jude Children's Research HospitalEnrolling: 651 location
RECRUITINGNCT07001631

Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease

Children with sickle cell disease may experience frequent painful episodes. This, together with the traumatic experiences during a hospitalization, can lead to the development of...

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Enrolling: 401 location
RECRUITINGPhase 1NCT07226219

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

The purpose of this study is to determine if patients with sickle cell disease (SCD) can consistently take a drug called Methylphenidate (MPH) daily, once a day for 4 weeks to...

Sponsor: St. Jude Children's Research HospitalEnrolling: 721 location
RECRUITINGNCT05099874

Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease

Children with sickle cell disease (SCD) exhibit significantly reduced cognitive functioning (often difficulties with attention) compared to peers and siblings without SCD....

Sponsor: Children's National Research InstituteEnrolling: 201 location
RECRUITINGNCT05359991

Exercise in Child Health

This study is a cooperative investigation funded by the NIH. The project is a collaboration among three major NIH Clinical Translational Science Awardees: 1) UCI (lead site with...

Sponsor: University of California, IrvineEnrolling: 2401 location
RECRUITINGNCT03937817

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Background: Blood disorders like sickle cell disease and malaria affect many people around the world. Researchers want to learn more about blood disorders. To do this, they need...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 3001 location
RECRUITINGPhase 2NCT03587272

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

This multisite prospective study seeks to determine if HLA-identical sibling donor transplantation using alemtuzumab, low dose total-body irradiation, and sirolimus (Sickle...

Sponsor: Robert NickelEnrolling: 1007 locations
RECRUITINGPhase 2NCT05336201

Cognitive Remediation Intervention to Prepare for Transition of Care

Randomized Controlled Trial (RTC) testing the efficacy of a telehealth adaptation of the Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-READY) intervention...

Sponsor: University of Alabama at BirminghamEnrolling: 1201 location
RECRUITINGNCT07246265

Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care

Background: Sickle cell disease is a genetic disorder of haemoglobin (which carries oxygen in red blood cells). The shape of sickle cell-patients' red blood cells is abnormal....

Sponsor: University Hospital, ToursEnrolling: 1006 locations
RECRUITINGPhase 1 / Phase 2NCT06930703

Cannabidiol in Sickle Cell Disease

Randomized, placebo-controlled, double masked, dose finding study of twice daily cannabidiol given at 3 dose levels, 200mg, 400mg, and 600mg, compared to placebo for 4 weeks.

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 521 location
RECRUITINGNCT07356050

Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children...

The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 1303 locations
RECRUITINGPhase 2NCT06260891

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

The goal of this short term prospective Phase II study is to compare the effects of two alternate daily doses of zinc (25 and 40 mg/day) in 34 randomly assigned homozygous Sickle...

Sponsor: University of California, San FranciscoEnrolling: 346 locations
RECRUITINGPhase 1 / Phase 2NCT07432867

Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo,...

The purpose of this study is to evaluate the Safety and Efficacy of DREAM01, a gene therapy for Sickle Cell Disease (SCD). The therapy consists of transplanting autologous CD34+...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 151 location
RECRUITINGPhase 2NCT06290401

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

The goal of this clinical trial is to evaluate the impact of SCThrive (a behavioral self-management intervention) on patient activation, self-management behaviors, daily...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 3104 locations
RECRUITINGNCT04093986

Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

The purpose of this research study is to document and understand the effects of hydroxyurea exposure for women with SCD and their babies, during both gestation and lactation.

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 2001 location
RECRUITINGNCT04406818

Metabolic and Hemodynamic Reserve in Pediatric SCA

The purpose of this research study is to better understand how blood flow and metabolism change can influence brain development in the early decades of life. SCA participants and...

Sponsor: Washington University School of MedicineEnrolling: 1201 location
RECRUITINGPhase 1NCT06647979

Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies

A promising approach for the treatment of genetic diseases is called gene therapy. Gene therapy is a relatively new field of medicine that uses genetic material (mostly DNA) from...

Sponsor: Daniel BauerEnrolling: 101 location
RECRUITINGNCT05799118

Study of the Role of Genetic Modifiers in Hemoglobinopathies

This study will investigate the role of genetic modifiers in hemoglobinopathies through a large-scale, multi-ethnic genome-wide association study (GWAS).

Sponsor: Cyprus Institute of Neurology and GeneticsEnrolling: 3000020 locations
RECRUITINGNCT06691867

Integrative Training Program for Pediatric Sickle Cell Pain

This research aims to answer the question: does a group training program specifically for teens with chronic sickle cell disease (SCD) pain that teaches skills to strengthen the...

Sponsor: Emory UniversityEnrolling: 1554 locations
RECRUITINGNCT06619197

Exploratory Study on Global Reflexology in Sickle Cell Disease

Sickle cell disease (or sickle cell anemia) is the most common genetic disease in France with 586 children screened in 2019. This chronic disease is characterized by the presence...

Sponsor: Hospices Civils de LyonEnrolling: 301 location
RECRUITINGNCT07090668

Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering...

The goal of this study is to evaluate the effects of transauricular vagus and trigeminal nerve stimulation on the treatment of pain in children with Sickle Cell Disease. * The...

Sponsor: Emory UniversityEnrolling: 201 location
RECRUITINGEarly Phase 1NCT06313398

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

Background: Sickle cell disease (SCD) is an inherited disorder of the blood. SCD causes red blood cells (RBCs) to die early. This can lead to a shortage of healthy cells. SCD and...

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)Enrolling: 1001 location
RECRUITINGPhase 2NCT05519111

Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain

A randomized, double blind, study of dronabinol as a palliative agent in the treatment of pain, inflammation, and other complications of sickle cell disease (SCD).

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 601 location
RECRUITINGNCT06919224

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

In a hybrid type I effectiveness-implementation trial, our three-center research teams aim to examine whether empowering adults with sickle cell disease (SCD) with patient-facing...

Sponsor: Ohio State UniversityEnrolling: 2874 locations
RECRUITINGPhase 1 / Phase 2NCT06144749

A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects...

This is a multi-center, open label Phase 2a clinical trial in subjects with sickle cell disease to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of HBI-002,...

Sponsor: Hillhurst Biopharmaceuticals, Inc.Enrolling: 92 locations
RECRUITINGNCT06944067

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With...

The purpose of this research study is to look at genes and determine how they interact with each other to find changes that could explain why some people's immune systems may...

Sponsor: National Human Genome Research Institute (NHGRI)Enrolling: 501 location
RECRUITINGNCT06074198

Sickle Cell Children's Exercise Study (SuCCESs)

The Sickle Cell Children's Exercise Study (SuCCESs) will explore the feasibility and effects of a moderate intensity strengthening, balance, speed, and agility intervention...

Sponsor: University of Maryland, BaltimoreEnrolling: 202 locations
RECRUITINGPhase 1NCT05904093

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell...

Background: Sickle cell disease (SCD) is a genetic disease that causes the body to produce abnormal ( sickled ) red blood cells. SCD can cause anemia and life-threatening...

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)Enrolling: 251 location
RECRUITINGNCT02280733

A Real-World Registry of Chronic Wounds and Ulcers

WOUNDJOURNEY is a longitudinal, real-world, observational registry designed to capture the full clinical course and patient journey associated with chronic wounds and ulcers. Data...

Sponsor: U.S. Wound RegistryEnrolling: 3000001 location
RECRUITINGPhase 2NCT03121001

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

The study is a Phase II clinical trial. Patients will receive intensity modulated total body irradiation (TBI) at a dose of 3 Gy with standard fludarabine/ i.v. cyclophosphamide...

Sponsor: University of Illinois at ChicagoEnrolling: 501 location
RECRUITINGPhase 1 / Phase 2NCT06417411

LEARNER- Low dosE AspiRiN prEterm tRial (Angola)

This study is being conducted to evaluate the safety and effect of starting daily use of low dose (100 mg) aspirin in pregnant women with sickle cell disease, who are being...

Sponsor: Instituto Nacional de Investigacao em Saude, AngolaEnrolling: 4501 location
RECRUITINGNCT07373639

A Long-term Follow-up Study in Patients Who Received BEAM-101

This is a Long-term Follow-up (LTFU) study in patients who received BEAM-101 in the parent study (Study BTX-AUT-001). Eligible patients who received BEAM-101 will be asked to...

Sponsor: Beam Therapeutics Inc.Enrolling: 5017 locations
RECRUITINGNCT07116772

Serial Assessment of Fertility Experiences

The SAFE study is a long-term research project that watches people with sickle cell anemia (SCA) over time. The main goal is to see how a medicine called hydroxyurea affects their...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 2503 locations
RECRUITINGNCT06497153

Lung Ultrasound in Pediatric Acute Chest Syndrome

Sickle-cell disease is a common disease with serious complications, in particular acute chest syndrome (ACS), which can be life threatening. The pathophysiology of ACS is poorly...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 601 location
RECRUITINGPhase 2NCT05736419

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive...

Hematopoietic Cell Transplantation/HCT involves receiving healthy blood-forming cells (stem cells) from a donor to replace the diseased or damaged cells in participants' bone...

Sponsor: Memorial Sloan Kettering Cancer CenterEnrolling: 246 locations
RECRUITINGPhase 3NCT06609226

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Etavopivat is a new medicine under development for treating blood disorders like sickle cell disease and thalassaemia. Sickle cell disease and thalassaemia are inherited blood...

Sponsor: Novo Nordisk A/SEnrolling: 48020 locations
RECRUITINGPhase 1 / Phase 2NCT04008368

Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid...

Background: Sickle cell disease can often be treated with blood stem cell transplants. But for some people the disease returns. This study will give a second transplant to people...

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)Enrolling: 321 location
RECRUITINGPhase 2NCT06872333

Allo HSCT for High Risk Hemoglobinopathies

A single center, open label, interventional, phase II trial for donor transplant for high risk hemoglobinopathies and other red cell transfusion dependent disorders utilizing...

Sponsor: Masonic Cancer Center, University of MinnesotaEnrolling: 621 location
RECRUITINGNCT05153967

Cooperative Assessment of Late Effects for SCD Curative Therapies

Sickle Cell Disease is one of the most common genetic diseases in the United States, occurring in approximately 1 in 400 births. Approximately 100,000 individuals are diagnosed...

Sponsor: Vanderbilt University Medical CenterEnrolling: 7505 locations
RECRUITINGNCT06464458

Optimizing the Management of Sickle Cell Patients on Hydroxyurea: The Value of Therapeutic Pharmacological Monitoring

Brief Summary: \* A short description of the clinical study, including a brief statement of the clinical study's hypothesis, written in language intended for the lay public....

Sponsor: University Hospital, Strasbourg, FranceEnrolling: 301 location
RECRUITINGPhase 1 / Phase 2NCT04156893

RH Genotype Matched RBC Transfusions

To determine the feasibility and efficacy of matching donor red cells by RH genotype for a cohort of chronically transfused patients with SCD.

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 351 location
RECRUITINGNCT03786549

Pediatric -Adult Care Transition Program of Patients With Sickle Cell Disease

Background The pediatric-adult care transition is a risk-disrupting time for patients with chronic disease. This care transition takes place during adolescence; a period of...

Sponsor: Hospices Civils de LyonEnrolling: 1968 locations
RECRUITINGNCT06887907

Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient

Sickle cell disease is the most common inherited blood disorder in the world. Chronic hemolysis induces platelet activation and chronic inflammation. Platelets and megakaryocyte,...

Sponsor: University Hospital, ToulouseEnrolling: 401 location
RECRUITINGNCT07083531

Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait

This is a cross-sectional, clinical research study comparing postmenopausal women of African Descent (AD) with different hemoglobin genotypes: normal and sickle cell trait (SCT)....

Sponsor: UConn HealthEnrolling: 501 location
RECRUITINGPhase 3NCT05392894

RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease

The purpose of this clinical trial is to evaluate the clinical and cost effectiveness of Haploidentical Stem Cell Transplantation (SCT) for adults with severe sickle cell disease...

Sponsor: King's College Hospital NHS TrustEnrolling: 1201 location
RECRUITINGPhase 4NCT06979492

Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease

The goal of this study is to determine if there is a positive effect of prophylactic red blood cell (RBC) transfusion of leukoreduced, ABO, Rh (D/Cc/Ee) and Kell matched blood...

Sponsor: Emory UniversityEnrolling: 501 location
RECRUITINGPhase 3NCT05378555

Oral Ketamine for Treatment of Vaso-Occlusive Pain

The purpose of this study is to learn more about the feasibility of oral ketamine for the treatment of painful sickle-cell crises in children and adolescents as a supplement to...

Sponsor: Boston Children's HospitalEnrolling: 101 location

Showing 50 of 103 trials.Search all Sickle Cell Disease trials